Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and Lovastatin-Reference-Cited by-同舟云学术

Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and Lovastatin

Published:1990-12 Issue:12 Volume:30 Page:1128-1135
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Pan Henry Y.,DeVault Arthur R.,Wang-Iverson David,Ivashkiv Eugene,Swanson Brian N.,Sugerman A. Arthur

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1990.tb01856.x/fullpdf

Reference28 articles.

1. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: Tissue-selective inhibitor of sterol synthesis and hypolipidemic effect on various animal species;Tsujita;Biochim Biophys Acta,1986

2. The effect of CS-514 on serum lipids and apolipoproteins in hypercholesterolemic subjects;Nakaya;JAMA,1987

3. Effects of SQ 31,000, a tissue-selective HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia;SQ 31,000 Multicenter Study Group I;Arteriosclerosis,1987

4. The Clinical Pharmacology of SQ 31,000 (CS 514) in Healthy Subjects

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers;Cancers;2023-12-23

2. Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma;International Journal of Molecular Sciences;2022-12-21

3. Reduction effect of oral pravastatin on the acute phase response to intravenous zoledronic acid: protocol for a real-world prospective, placebo-controlled trial;BMJ Open;2022-07

4. In vivo evaluation of combination therapy targeting the isoprenoid biosynthetic pathway;Pharmacological Research;2021-05

5. Pharmacokinetic interaction between atorvastatin and fixed-dose combination of sofosbuvir/ledipasvir in healthy male Egyptian volunteers;European Journal of Clinical Pharmacology;2021-04-01